- Home
- FEBO vs XXII Comparison
FEBO vs XXII Comparison
Compare FEBO & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FEBO | XXII |
|---|---|---|
| Founded | 1993 | 1998 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4M | 7.8M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | FEBO | XXII |
|---|---|---|
| Price | $1.33 | $0.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 147.2K | ★ 171.1K |
| Earning Date | 12-30-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $17,110,653.00 | ★ $20,346,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $136.46 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 11.58 | ★ 16.98 |
| 52 Week Low | $0.61 | $0.78 |
| 52 Week High | $2.31 | $287.27 |
Technical Indicators
Market Signals| Indicator | FEBO | XXII |
|---|---|---|
| Relative Strength Index (RSI) | 82.81 | 40.75 |
| Support Level | $0.84 | $0.96 |
| Resistance Level | $1.39 | $1.08 |
| Average True Range (ATR) | 0.12 | 0.08 |
| MACD | 0.06 | 0.00 |
| Stochastic Oscillator | 91.14 | 17.23 |
Price Performance
Historical ComparisonAbout FEBO Fenbo Holdings Limited
Fenbo Holdings Ltd is a company engaged in producing premium personal care electric appliances, principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.